Some pharmacoeconomic aspects of epilepsy in adult patients

Autor: Dubenko, A. Ye., Sazonov, S. O., Kutikov, D. O., Kutikov, O. Ye., Kolesnik, T. M.

Publikováno v: Клінічна фармація; Том 24, № 3 (2020); 30-38
Clinical pharmacy; Том 24, № 3 (2020); 30-38
Клиническая фармация; Том 24, № 3 (2020); 30-38
Clinical pharmacy; Vol. 24 No. 3 (2020); 30-38
Клиническая фармация; Том 24 № 3 (2020); 30-38
Клінічна фармація; Том 24 № 3 (2020); 30-38

According to some publications, epilepsy accounts for 0.6 % of the global burden of diseases, and the cost of treatment of one patient with epilepsy reaches 88.2 % of the gross national product per capita. All this determines a great importance of ph

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::59457a61bb341fb6a3c7b7f71e7009ce
http://cphj.nuph.edu.ua/article/view/cphj.20.1535